Showing results (1-10 of 44) with videos related to
Sort By:
Pageof 5
Journal of Oncology|December 29, 2011
Oxaliplatin-induced neuropathy in colorectal cancerAndrew Weickhardt, Keith Wells, Wells MessersmithExpert Opinion on Investigational Drugs|February 28, 2003
Recent advances in the pharmacological treatment of colorectal cancerWells Messersmith, Daniel Laheru, Manuel HidalgoClinical Colorectal Cancer|September 10, 2011
Development of novel targeted agents in the treatment of metastatic colorectal cancerEamon Berge, Chris Thompson, Wells MessersmithSeminars in Oncology|August 4, 2011
Promising targets and drugs in development for colorectal cancerChris Thompson, Stephen Leong, Wells MessersmithJournal of Clinical Neurology (Seoul, Korea)|July 22, 2014
Anti-ma2 paraneoplastic encephalitis in association with recurrent cervical cancerDouglas E Ney, Wells Messersmith, Kian BehbakhtSeminars in Interventional Radiology|May 3, 2012
Chemotherapy agents: a primer for the interventional radiologistFrank Mihlon, Charles E Ray, Wells MessersmithThe Oncologist|April 28, 2011
Current status of SRC inhibitors in solid tumor malignanciesLauren N Puls, Matthew Eadens, Wells MessersmithInvestigational New Drugs|February 28, 2006
Binding of gefitinib, an inhibitor of epidermal growth factor receptor-tyrosine kinase, to plasma proteins and blood cells: in vitro and in cancer patientsJing Li, Julie Brahmer, Wells Messersmith, et al.Plos One|May 8, 2015
ALDH1B1 Is Crucial for Colon Tumorigenesis by Modulating Wnt/β-Catenin, Notch and PI3K/Akt Signaling PathwaysSurendra Singh, John Arcaroli, Ying Chen, et al.Cancer Biology & Therapy|December 2, 2005
Assessment of Epidermal Growth Factor Receptor (EGFR) signaling in paired colorectal cancer and normal colon tissue samples using computer-aided immunohistochemical analysisWells Messersmith, Darin Oppenheimer, Josep Peralba, et al.Pageof 5